OKYO announces the appointment of Dr Rajkumar Patil as Chief Scientific Officer
OKYO Pharma Limited (OKYO.L) Appointment of Chief Scientific Officer
OKYO Pharma Limited (OKYO.L) Patent for treating Ocular Pain and Inflammation
OKYO Pharma has U.S. Patent Issued Covering its Lipid Conjugated Peptide Analogues for treating Ocular Pain and Inflammation
Share Talk Bulletin Board Heroes, Tuesday 19th January 2021
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.
OKYO PHARMA LIMITED (OKYO.L) Filing patent application for the use of Chemerin
OKYO announces filing of a patent application covering the use of Chemerin and associated analogues to treat “cytokine storm” associated with COVID-19 and ARDS
Share Talk Bulletin Board Heroes, Wednesday 13th January 2021
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.
Weekend Edition, Bulletin Board Heroes, Sunday 6th December 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.
Pharma Special, Bulletin Board Heroes, Tuesday 27th October 2020
Zak Mir highlights some of the most followed pharmaceutical stocks on the small-cap London market and gives an overview in this video charting update.
Share Talk Bulletin Board Heroes, Friday 9th October 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this video charting update.
OKYO PHARMA LIMITED (OKYO.L) Grant of options – Director dealings
OKYO Pharma Limited (LSE: OKYO) (“OKYO” or the “Company”), the life sciences and biotechnology company, focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases
OKYO PHARMA LIMITED (OKYO.L) Dr. Napoleone Ferrara to Serve on Its Scientific Advisory Board
OKYO , the life sciences and biotechnology company, focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and chronic pain, is pleased to announce
Stock Market Watch: QFI, EUA, OKYO, TILS, SYME, PET, ZIOC & NQMI
Stocks that may or may not make the grade in the papers
